Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

Imfinzi plus BCG therapy significantly improved DFS in high-risk NMIBC patients compared to BCG alone, as shown in the POTOMAC phase 3 trial. The trial was not statistically powered for overall ...

Immunotherapy activates your immune system to kill bladder cancer cells. Trimodal therapy (TMT) removes the bladder tumor followed by chemotherapy and radiation treatments. TMT combines surgery ...

“Today’s approval for Imfinzi represents a paradigm shift, bringing the first perioperative immunotherapy to patients in the US with muscle-invasive bladder cancer and addressing a significant ...

That makes the therapy especially useful for cancer near the brain and the spine. The 14,000-square-foot Danbury Proton facility, planned for a 3-acre site on Wooster Heights Road overlooking ...

multicenter investigation which enrolled 1,063 patients who were candidates for radical cystectomy (surgery to remove the urinary bladder) and had not yet received prior systemic therapy for their ...

SAN DIEGO, Calif. (Ivanhoe Newswire) - A breakthrough in bladder cancer treatment is helping to save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will ...

Jan 10 (Reuters) - Pfizer's (PFE.N), opens new tab experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of certain complications ...

FRIDAY, Dec. 6, 2024 (HealthDay News) -- There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with ...

At six months, Protara Therapeutics’ investigational cell therapy elicited a complete response (CR) rate of 72% among 18 patients with bladder cancer, data that sent the biotech’s shares surging.